tiprankstipranks
Trending News
More News >

Belluscura PLC Reports Strong Q1 Sales and Announces CFO Resignation Amid Tariff Challenges

Story Highlights
Belluscura PLC Reports Strong Q1 Sales and Announces CFO Resignation Amid Tariff Challenges

Don’t Miss TipRanks’ Half-Year Sale

Belluscura PLC ( (GB:BELL) ) has issued an update.

Belluscura PLC reported a significant increase in Q1 2025 sales to $912,000, up from $166,000 in Q1 2024. Despite facing a 20% tariff on products sold in the US due to new import duties on Chinese and Hong Kong goods, the company is exploring ways to mitigate these costs. The launch of the X-PLOR 5, a lightweight, FDA-cleared portable oxygen concentrator, has seen strong initial demand, and the DISCOV-R is expected to launch commercially in Q3 FY25. Additionally, the company announced the resignation of CFO Simon Neicheril, with Chairman Paul Tuson temporarily assuming financial responsibilities.

More about Belluscura PLC

Belluscura PLC is a leading medical device developer specializing in lightweight and portable oxygen enrichment technology. The company focuses on creating innovative solutions for oxygen therapy, with a market emphasis on portable oxygen concentrators.

YTD Price Performance: -91.89%

Average Trading Volume: 2,381,965

Technical Sentiment Signal: Buy

Current Market Cap: £3.01M

For a thorough assessment of BELL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1